ROS1 and pulmonary emphysema: In the ALK&ROS1‐positive group, the most were female (χ2 = 7.644, P = 0.008) patients, and proportion of patients with emphysema was lower (χ2 = 8.202, P = 0.003) than the ALK&ROS1‐negative group.